MENU

CSL clinical studies prove successful

CSL (ASX: CSL) has a long and proud history of developing therapies to improve patients’ lives. This week CSL announced  promising results from “clinical studies involving a new group of therapies for the treatment of haemophilia”.

One of the beauties of CSL’s business model has been the company’s ability to innovate therapies, through research and development, which improve upon and expand upon its current sales base. CSL has for many years provided blood plasma products to treat hemophilia  so news of a potential new therapy for bleeding disorders (including hemophilia) and the associated development have low business risks given CSL already knows the market well and services it extensively.

Another firm which also has a similarly low-risk business model is implantable hearing device company Cochlear (ASX: COH). Cochlear is continually innovating improvements to its products, which effectively value adds to its current customer base.

The quality of these two firms’ business models has been reflected in their share prices, with CSL and Cochlear up 84% and 37% respectively over the past five years. In comparison the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO) is down around 4% over the same period.

In the market for high-yielding ASX shares? Get “3 Stocks for the Great Dividend Boom” in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading


Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

5 ASX Stocks for Building Wealth After 50

I just read that Warren Buffett, the world’s best investor, made over 99% of his massive fortune after his 50th birthday.

It just goes to show you… it’s never too late to start securing your financial future.

And Motley Fool Chief Investment Advisor Scott Phillips just released a brand-new report that reveals five of our favourite ASX stocks for building wealth after 50.

– Each company boasts strong growth prospects over the next 3 to 5 years…

– Most importantly each pays a generous dividend, fully franked.

Simply click here to find out how you can claim your FREE copy of “5 ASX Stocks for Building Wealth After 50.”

See the stocks now